Morgan Stanley

About Morgan Stanley

Morgan Stanley provides financial services through Wealth Management, Institutional Securities and Investment Management. Wealth Management serves individuals and businesses with financial advice, brokerage, lending and investment products; Institutional Securities serves corporations, governments and institutional investors with investment banking, trading and related services; Investment Management manages assets for institutional and individual clients. The company earns fees, commissions and interest as well as revenue from underwriting, advisory and trading activity. An Aries analyst-page snippet puts Wealth Management at 45% of revenue. Morgan Stanley reports net income of $16.9 billion for FY2025, up from $13.4 billion in FY2024; the supplied revenue figures are unavailable.

Notable Price Movement

1. Oct 26-30$184.302.68%

   Morgan Stanley rose 3.28% over the stated week, from $183.97 to $190.00. Trading was uneven around the start: the shares fell to $179.49 on October 23, then recovered to $183.49 on October 26 and advanced for the next two sessions, closing at $190.13 on October 28 before edging down to $190.00 on October 29. The supplied evidence identifies no company-specific announcement or dated event that explains the rise or the final-session pullback. Articles discuss wealth-management AI and compare Morgan Stanley with Goldman Sachs, but do not establish either as a catalyst during this week. No broad-market benchmark or other market data is supplied, so the move cannot be attributed to wider market conditions.

   21 sources
2. Oct 19-23$179.490.60%

   Morgan Stanley fell 6.08%, from $190.02 to $178.47, over the supplied October 12–19 closes. The largest declines came on October 13 and 14, when shares dropped to $181.51; they recovered slightly on October 15, then resumed falling on October 16 and 19. The evidence does not establish a company-specific cause for the early-week selloff. After Q3 results, analysts cut price targets: Morgan Stanley lowered its target to $210 from $215 on October 16, while Keefe, Bruyette & Woods analyst Christopher McGratty cut his target to $230 from $250 and reiterated Outperform. Those revisions point to a more cautious post-results outlook, but the supplied evidence does not show that they drove the full weekly decline.

   28 sources
3. Oct 12-16$180.574.97%

   Morgan Stanley shares fell 0.09%, from $190.19 to $190.02, over the supplied October 5–12 closes. The stock rose to $191.02 on October 6, then slid to $187.44 by October 8 before recovering to $190.02 on October 9 and holding there on October 12. Earnings coverage reported a Q3 beat, with equity trading and wealth growth highlighted, but MarketBeat said shares fell on trading mix, while subsequent analyst coverage pointed to forecast cuts and concerns about whether strong flows would endure. Those competing signals fit the sharp midweek pullback and recovery, but the supplied evidence does not establish the dates of the earnings coverage or any broader market driver.

   28 sources
4. Oct 5-9$190.020.15%

   Morgan Stanley shares fell 0.90%, from $192.76 to $191.02, over the supplied period. The main move came early: the stock dropped to $188.08 on September 30 and $188.01 on October 1, then rebounded to $190.31 on October 2. It was nearly unchanged on October 5 and rose to $191.02 on October 6. The evidence does not identify a company-specific announcement behind these swings. Kalkine Media’s coverage focused on upcoming earnings and wealth-management and trading strength, but supplied no new results or guidance to explain the price action. The stock therefore moved without an evidenced company-specific catalyst; no market benchmark or broader market driver was supplied for comparison.

   28 sources
5. Sep 28 - Oct 2$190.313.06%

   Morgan Stanley fell 4.23%, from $196.32 to $188.01, over the reported week. The decline was steady rather than a sharp reversal: shares closed at $193.64 on Monday, $192.76 on Tuesday, then dropped 2.43% to $188.08 on Wednesday; Thursday added a further small decline, with volume rising to 9.55 million shares. No supplied evidence identifies a company-specific announcement as the trigger. Zacks articles discuss higher rates as a potential support for Wealth Management and describe the stock as oversold after a longer decline, but they do not link those themes to a specific event during this week. The evidence provides no market benchmark or broader-market context to explain the move.

   22 sources
6. Sep 21-25$196.313.10%

   Morgan Stanley fell 1.99%, from $202.42 to $198.39 over the supplied span. The stock rose to $206.12 on Monday, September 21, gaining 1.75% from the prior close, but reversed sharply over the next two sessions: it dropped 2.88% Tuesday and another 0.89% Wednesday. The supplied evidence identifies no company-specific event driving the reversal. Market context was unfavorable for financial shares on Tuesday: Barchart reported that financial stocks fell as the broader market finished mixed, with the S&P 500 unchanged, the Dow down 0.36% and the Nasdaq 100 up 0.82%. The available evidence does not establish that this sector move fully explains Morgan Stanley’s decline.

   28 sources
7. Sep 14-18$202.585.50%

   Morgan Stanley fell 5.12%, from $217.72 to $206.58 over the supplied week, with the decline concentrated in the final session. The stock had already eased from $217.72 on September 4 to $214.38 on September 11, then dropped 3.64% on September 14 on volume of 7.50 million shares, well above the roughly 3.1 million to 4.5 million shares in the preceding sessions. The supplied evidence does not identify a company-specific earnings release, guidance change, or named analyst action explaining the selloff. Coverage instead included discussion that the shares looked fairly priced as a crash warning loomed and that fund momentum may have shifted, but neither snippet establishes causation. No broader market benchmark or macro catalyst was supplied.

   28 sources
8. Sep 7-11$214.381.53%

   Morgan Stanley rose $2.92, or 1.37%, from $213.32 to $216.24 over the reported week. The stock initially weakened, falling to $211.04 on September 1 from $213.32 on August 31, before recovering modestly to $211.82 the next day. It then advanced sharply to $217.15 on September 3 and $217.72 on September 4, gaining more than 2.7% from the weekly low. By September 8, it had given back part of that rally, closing at $216.24. The supplied evidence identifies no company-specific announcement or attributable analyst action driving the move. Relevant coverage instead discussed Morgan Stanley’s relative performance and a more significant dip than the broader market, leaving market and trading factors as the clearest explanation.

   28 sources
9. Aug 31 - Sep 4$217.721.37%

   Morgan Stanley rose $2.29, or 1.07%, from $214.86 to $217.15 over the week, despite a sharp early pullback. The stock fell to $213.32 on Monday and $211.04 on Tuesday, with Zacks attributing Tuesday’s 1.07% decline to weakness greater than the broader market. It recovered modestly on Wednesday before surging 2.51% on Thursday to finish at the weekly high. No company-specific announcement or analyst action in the supplied evidence clearly explains the reversal. The week’s backdrop included a reported ETF inflow involving MS and a Zacks industry view that investment banks could benefit from stronger deal activity, trading and technology spending, but the evidence does not establish either as the direct cause of Thursday’s rally.

   28 sources
10. Aug 24-28$214.770.27%

    Morgan Stanley rose $7.41, or 3.57%, over the week, closing at $214.86 versus $207.45. It started near $214.20 on Aug. 21 and slipped marginally Monday to $214.08, then advanced 1.26% Tuesday to $216.77 before giving back most of that gain Wednesday, falling to $214.08. Thursday brought a modest recovery to $214.86. No company-specific announcement or attributable analyst target change was supplied to explain the day-to-day pattern. Positive background coverage highlighted Morgan Stanley’s strong first-half 2026 results, improving diversification and investment-banking recovery, while broader trading was cautious ahead of Nvidia’s earnings as Treasury yields rose. This mix is consistent with a firm-specific positive bias despite muted market conditions.

    28 sources
11. Aug 17-21$214.201.45%

    Morgan Stanley fell 5.01% over the week, from $218.38 to $207.45. The stock initially stabilized, rising to $218.21 on Monday after the prior Friday’s modest decline, then slipped to $217.55 on Tuesday. Selling accelerated Wednesday, when it dropped to $214.23 on 4.91 million shares, and intensified Thursday with a further decline to $207.45 on 4.88 million shares. The supplied evidence identifies no company-specific earnings release, guidance change, transaction, or analyst action dated during the week that explains the reversal and late-week volume increase. Articles concerning a former-advisor lawsuit, a preferred security’s yield, an upcoming co-president appearance, and Morgan Stanley’s AI power-gap research do not state that they drove the common stock. No market benchmark or sector catalyst is provided.

    28 sources
12. Aug 10-14$217.360.48%

    Morgan Stanley rose $4.10, or 1.94%, from $211.23 to $215.33 over the week. Trading was volatile rather than steadily upward: the stock jumped $5.81 on August 4 on volume of 8.9 million shares, added another $1.23 on August 5, then gave back $4.52 on August 6. It recovered $2.58 on August 7 before slipping $1.00 on August 10. The supplied evidence does not identify company-specific news that explains the net gain or the reversals. An Eaton Vance item about redeeming remaining auction preferred shares is company-related but provides no stated financial impact on Morgan Stanley. Broader market context is also not supplied.

    28 sources
13. Aug 3-7$216.332.81%

    Morgan Stanley rose $5.46, or 2.58%, from $211.58 to $217.04 over the week. Trading was volatile: the stock fell $8.45 on July 29, then recovered $6.93 on July 30 and added modestly on July 31 and August 3 before jumping $5.81 on August 4. The final-day advance came with volume of 8.93 million shares, well above the prior session’s 4.98 million. The supplied evidence does not identify a dated company-specific catalyst for the move. Morgan Stanley’s new Ethereum and Solana ETFs and UBS’s higher target are relevant investor themes, but neither is explicitly tied to a trading day. The stock therefore appears to have moved mainly without documented company-specific news.

    20 sources

Stories & Analysis

J.P. Morgan Just Made a Bold Prediction About Bitcoin. Should You Buy It?The Motley Fool · 3d agoIs Trending Stock Morgan Stanley (MS) a Buy Now?Zacks · 4d agoThe Humanoid Robot Market Could Be Worth More Than $7 Trillion. Here Are 3 Stocks to Own.The Motley Fool · 5d agoRaymond James Q4 Earnings Beat Estimates, Revenues Rise Y/YZacks · 5d agoThe Pentagon Is Now the eVTOL Industry's Biggest Customer. Here's How Much Revenue That's Actually Worth to Archer and Joby.The Motley Fool · Oct 28Palantir Technologies and Yum! Brands have been highlighted as Zacks Bull and Bear of the DayZacks · Oct 28Morgan Stanley's Preferred Stock, Series A Shares Cross 6.5% Yield MarkBNK Invest · Oct 27Can AI Adoption Sustain Morgan Stanley's Wealth Management Growth?Zacks · Oct 27